Advanced Biomed Inc. Common Stock - Asset Resilience Ratio
Advanced Biomed Inc. Common Stock (ADVB) has an Asset Resilience Ratio of 0.09% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See ADVB working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (None–None)
This chart shows how Advanced Biomed Inc. Common Stock's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is Advanced Biomed Inc. Common Stock's balance sheet.
Liquid Assets Composition Over Time
This chart breaks down Advanced Biomed Inc. Common Stock's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Advanced Biomed Inc. Common Stock total liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $9.99K | 0.09% |
| Total Liquid Assets | $9.99K | 0.09% |
Asset Resilience Insights
- Limited Liquidity: Advanced Biomed Inc. Common Stock maintains only 0.09% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Advanced Biomed Inc. Common Stock Industry Peers by Asset Resilience Ratio
Compare Advanced Biomed Inc. Common Stock's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
GeneDx Holdings Corp.
NASDAQ:WGS |
Diagnostics & Research | 15.00% |
|
Integral Diagnostics Ltd
AU:IDX |
Diagnostics & Research | 0.03% |
|
Healius Ltd
AU:HLS |
Diagnostics & Research | 0.06% |
|
Microba Life Sciences Ltd
AU:MAP |
Diagnostics & Research | 11.53% |
|
Genetic Signatures Ltd
AU:GSS |
Diagnostics & Research | 60.91% |
|
Sonic Healthcare Ltd
AU:SHL |
Diagnostics & Research | 0.13% |
|
Australian Clinical Labs Ltd
AU:ACL |
Diagnostics & Research | 4.11% |
|
Monash Ivf Group Ltd
AU:MVF |
Diagnostics & Research | 1.60% |
Annual Asset Resilience Ratio for Advanced Biomed Inc. Common Stock (None–None)
The table below shows the annual Asset Resilience Ratio data for Advanced Biomed Inc. Common Stock.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| No yearly data available. | ||||
About Advanced Biomed Inc. Common Stock
Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan. Its devices include A+Pre, an automated sample preparation system that enables pre-concentration of diluted blood samples; AC-1000, a rare cell device to solve the problem of detection of hypercoagul… Read more